A1 / F / 37 / Breast / Normal breast tissue / - / - / - / +~++, 50% / +++, 70% / - / - / +/- / Normal
A2 / F / 37 / Breast / Normal breast tissue / - / - / - / ++~+++, 70% / +++, 20% / - / - / +/- / Normal
A3 / F / 43 / Breast / Normal / hyperplasia / - / - / - / +++, 95% / +++, 60% / - / - / +/- / Normal
A4 / F / 43 / Breast / Normal breast tissue / - / - / - / +++, 90% / +++, 60% / - / - / +/- / Normal
A5 / F / 46 / Breast / Normal breast tissue / - / - / - / +++, 30% / +++, 40% / - / - / +/- / Normal
A6 / F / 46 / Breast / Normal breast tissue / - / - / - / +++, 30% / +++, 30% / - / - / +/- / Normal
A7 / F / 19 / Breast / Fibroadenoma / - / - / - / +++,30% / +++, 40% / +, 0.5% / ++, 1% / +/- / Benign
A8 / F / 19 / Breast / Fibroadenoma / - / - / - / +, 2% / +++, 30% / +, 0.5% / ++, 3% / +/- / Benign
A9 / F / 22 / Breast / Fibroadenoma / - / - / - / +, 1% / +++, 90% / +, 0.5% / ++, 10% / +/- / Benign
A10 / F / 22 / Breast / Fibroadenoma / - / - / - / +++, 99% / +++, 80% / +, 0.5% / ++, 5% / +/- / Benign
A11 / F / 54 / Breast / Fibroadenoma / - / - / - / - / - / - / - / - / Benign
A12 / F / 54 / Breast / Fibroadenoma / - / - / - / - / - / - / - / - / Benign
A13 / F / 69 / Breast / Cystosarcoma phyllodes / - / - / - / +++, 1% / ++, 0.5% / +, 5% / +, 1% / + / Malignant
A14 / F / 69 / Breast / Cystosarcoma phyllodes / - / - / - / +++, 1% / +++, 10% / +, 2% / +, 0.5% / ++ / Malignant
A15 / F / 49 / Breast / Cystosarcoma phyllodes / - / - / - / - / - / - / - / - / Malignant
B1 / F / 49 / Breast / Cystosarcoma phyllodes / - / - / - / - / - / - / - / - / Malignant
B2 / F / 58 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / - / - / - / +++, 80% / - / Malignant
B3 / F / 58 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / - / - / - / +++, 90% / - / Malignant
B4 / F / 45 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / ++~+++， 95% / +++, 99% / - / ++, 0.5% / + / Malignant
B5 / F / 45 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / ++~+++， 100% / +++, 99% / - / +, 0.1% / + / Malignant
B6 / F / 67 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / - / - / +++, 100% / +, 1% / +++ / Malignant
B7 / F / 67 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / - / - / +++, 100% / +++, 20% / +++ / Malignant
B8 / F / 38 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / - / +++, 90% / +, 0.5% / ++, 0.5% / ++ / Malignant
B9 / F / 38 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / - / +++, 98% / +, 0.5% / ++, 0.5% / ++ / Malignant
B10 / F / 43 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / +， 50% / - / ++, 50% / - / ++ / Malignant
B11 / F / 43 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / +++， 99% / ++, 1% / ++, 90% / ++, 0.5% / + / Malignant
B12 / F / 31 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / +++， 99% / +++, 40% / - / ++, 0.5% / ++ / Malignant
B13 / F / 31 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / +++， 100% / +++, 70% / - / ++, 0.5% / ++ / Malignant
B14 / F / 50 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / - / - / ++, 80% / ++, 40% / +++ / Malignant
B15 / F / 50 / Breast / Intraductal carcinoma / - / 0 / TisN0M0 / - / - / ++, 80% / ++, 35% / +++ / Malignant
C1 / F / 53 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 99% / ++, 2% / +, 5% / ++, 50% / ++ / Malignant
C2 / F / 53 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++，99% / ++, 5% / +, 5% / ++, 30% / ++ / Malignant
C3 / F / 46 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +, 0.5% / +++, 80% / ++ / Malignant
C4 / F / 46 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +, 0.5% / +++, 80% / ++ / Malignant
C5 / F / 50 / Breast / Invasive ductal carcinoma / 2 / IIIb / T4cN0M0 / - / - / - / +++, 70% / ++ / Malignant
C6 / F / 50 / Breast / Invasive ductal carcinoma / 2 / IIIb / T4cN0M0 / - / - / - / +++, 50% / ++ / Malignant
C7 / F / 50 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 99% / +++, 70% / +, 1% / +++, 10% / ++ / Malignant
C8 / F / 50 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 99% / ++, 70% / +, 1% / +++, 3% / ++ / Malignant
C9 / F / 54 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +++, 70% / +++, 5% / +++ / Malignant
C10 / F / 54 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +++, 80% / +++, 0.5% / +++ / Malignant
C11 / F / 45 / Breast / Invasive ductal carcinoma / 2 / II / T1N0M0 / +， 1% / - / +, 1% / +++, 1% / ++ / Malignant
C12 / F / 45 / Breast / Invasive ductal carcinoma / 2 / II / T1N0M0 / +， 1% / - / +, 0.5% / +++, 1% / ++ / Malignant
C13 / F / 52 / Breast / Invasive ductal carcinoma / - / IIIa / T2N2M0 / +++， 1% / - / ++, 1% / +++, 10% / ++ / Malignant
C14 / F / 52 / Breast / Invasive ductal carcinoma / 2 / IIIa / T2N2M0 / +++， 80% / +, 0.5% / ++, 50% / ++, 20% / +++ / Malignant
C15 / F / 64 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +, 30% / - / +++ / Malignant
D1 / F / 64 / Breast / Invasive ductal carcinoma / - / IIa / T2N0M0 / - / - / - / - / - / Malignant
D2 / F / 51 / Breast / Invasive ductal carcinoma / 2 / IIIa / T2N2M0 / - / - / +++, 95% / +++,80% / - / Malignant
D3 / F / 51 / Breast / Invasive ductal carcinoma / 2 / IIIa / T2N2M0 / - / - / +++, 80% / +++,70% / - / Malignant
D4 / F / 47 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N0M0 / +++， 100% / +++, 99% / +, 0.5% / +++, 8% / ++ / Malignant
D5 / F / 47 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N0M0 / +++， 100% / +++, 100% / +, 0.5% / +++, 0.5% / ++ / Malignant
D6 / F / 50 / Breast / Invasive ductal carcinoma / - / IIIa / T2N2M0 / - / - / - / +, 0.1% / - / Malignant
D7 / F / 50 / Breast / Invasive ductal carcinoma / 2 / IIIa / T2N2M0 / +， 60% / - / - / +++, 15% / +++ / Malignant
D8 / F / 48 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 100% / +++, 99% / +, 0.5% / +++, 60% / ++ / Malignant
D9 / F / 48 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 99% / +++, 99% / +, 0.5% / +++, 60% / ++ / Malignant
D10 / F / 38 / Breast / Invasive ductal carcinoma / 2 / IIb / T2N1M0 / - / - / ++, 70% / +, 1% / +++ / Malignant
D11 / F / 38 / Breast / Invasive ductal carcinoma / 2 / IIb / T2N1M0 / - / - / ++, 80% / +, 8% / +++ / Malignant
D12 / F / 34 / Breast / Invasive ductal carcinoma / 2 / IIIb / T4N0M0 / ++， 90% / - / +, 50% / +, 10% / ++ / Malignant
D13 / F / 34 / Breast / Invasive ductal carcinoma / 2 / IIIb / T4N0M0 / - / - / - / +, 0.1% / + / Malignant
D14 / F / 55 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 90% / - / - / +++,20% / +++ / Malignant
D15 / F / 55 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 80% / - / - / +++,20% / +++ / Malignant
E1 / F / 56 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 40% / ++, 8% / ++, 10% / ++, 10% / + / Malignant
E2 / F / 56 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 50% / +, 0.5% / ++, 10% / ++, 10% / + / Malignant
E3 / F / 39 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 50% / +++, 5% / - / +, 0.1% / + / Malignant
E4 / F / 39 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 40% / ++, 5% / - / - / - / Malignant
E5 / F / 60 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +, 5% / +++, 40% / +++ / Malignant
E6 / F / 60 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +, 5% / +++, 80% / +++ / Malignant
E7 / F / 43 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++, 90% / +++, 60% / - / +++, 30% / +++ / Malignant
E8 / F / 43 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++，90% / +++, 50% / - / ++-+++, 60% / +++ / Malignant
E9 / F / 46 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +++, 100% / +++, 90% / ++ / Malignant
E10 / F / 46 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +++, 100% / +++, 90% / ++ / Malignant
E11 / F / 53 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 99% / - / - / +++, 50% / ++ / Malignant
E12 / F / 53 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 90% / - / +, 10% / +++, 40% / + / Malignant
E13 / F / 46 / Breast / Invasive ductal carcinoma / 2 / IIIb / T4N0M0 / +++， 90% / +++, 40% / +, 20% / ++, 2% / +++ / Malignant
E14 / F / 46 / Breast / Invasive ductal carcinoma / 2 / IIIb / T4N0M0 / +++, 99% / +++,5% / - / ++, 10% / +++ / Malignant
E15 / F / 50 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / ++, 90% / ++, 1% / ++, 90% / ++, 10% / +++ / Malignant
F1 / F / 50 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / ++， 80% / ++, 40% / ++, 80% / ++, 20% / +++ / Malignant
F2 / F / 51 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N1M0 / - / - / +++, 100% / +++, 90% / +++ / Malignant
F3 / F / 51 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N1M0 / - / - / +++, 100% / +++, 90% / +++ / Malignant
F4 / F / 37 / Breast / Invasive ductal carcinoma / 2 / IIIb / T4N2M0 / - / - / +, 5% / +, 0.1% / +++ / Malignant
F5 / F / 37 / Breast / Invasive ductal carcinoma / 2 / IIIb / T4N2M0 / - / - / +, 5% / +, 5% / +++ / Malignant
F6 / F / 40 / Breast / Invasive ductal carcinoma / 3 / IIb / T2N1M0 / - / ++, 40% / - / +++, 40% / ++ / Malignant
F7 / F / 40 / Breast / Invasive ductal carcinoma / 2 / IIb / T2N1M0 / - / ++, 40% / - / ++, 45% / ++ / Malignant
F8 / F / 33 / Breast / Invasive ductal carcinoma / 2 / I / T1N0M0 / - / +++, 30% / - / +++, 1% / +++ / Malignant
F9 / F / 33 / Breast / Invasive ductal carcinoma / 2 / I / T1N0M0 / - / +++, 20% / +, 1% / +++, 20% / +++ / Malignant
F10 / F / 59 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 10% / - / +++, 80% / +++, 10% / ++ / Malignant
F11 / F / 59 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / +++， 70% / - / +++, 5% / +++, 20% / ++ / Malignant
F12 / F / 43 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +++, 99% / +++, 90% / ++ / Malignant
F13 / F / 43 / Breast / Invasive ductal carcinoma / - / IIa / T2N0M0 / No tissue / No tissue / No tissue / +++, 90% / No tissue / Malignant
F14 / F / 56 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N0M0 / +++， 90% / - / - / ++, 1% / ++ / Malignant
F15 / F / 56 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N0M0 / ++， 99% / ++, 25% / - / +, 0.5% / ++ / Malignant
G1 / F / 67 / Breast / Invasive ductal carcinoma / 2--3 / I / T1N0M0 / +， 10% / - / +, 40% / +++, 95% / ++ / Malignant
G2 / F / 67 / Breast / Invasive ductal carcinoma / 2--3 / I / T1N0M0 / ++， 50% / - / +, 50% / +++, 40% / ++ / Malignant
G3 / F / 51 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +, 50% / ++, 10% / ++ / Malignant
G4 / F / 51 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +, 50% / ++, 10% / ++ / Malignant
G5 / F / 34 / Breast / Invasive ductal carcinoma / 2--3 / IIa / T2N0M0 / +, 1% / - / ++, 70% / +++, 70% / +++ / Malignant
G6 / F / 34 / Breast / Invasive ductal carcinoma / 2--3 / IIa / T2N0M0 / +, 1% / - / ++, 60% / +++, 70% / +++ / Malignant
G7 / F / 49 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N0M0 / - / - / - / ++, 50% / + / Malignant
G8 / F / 49 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N0M0 / - / - / - / +, 40% / + / Malignant
G9 / F / 43 / Breast / Invasive ductal carcinoma / 2--3 / I / T1N0M0 / +, 2% / +++, 5% / +++, 70% / ++-+++, 95% / +++ / Malignant
G10 / F / 43 / Breast / Invasive ductal carcinoma / 2--3 / I / T1N0M0 / +, 10% / +++, 10% / +++, 50% / ++,30% / +++ / Malignant
G11 / F / 59 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +++, 90% / +, 1% / - / Malignant
G12 / F / 59 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +++, 20% / +, 1% / - / Malignant
G13 / F / 40 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / ++, 60% / +, 0.5% / +, 1% / + / Malignant
G14 / F / 40 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / ++, 50% / - / +, 1% / + / Malignant
G15 / F / 46 / Breast / Invasive ductal carcinoma / 2 / I / T1cN0M0 / ++, 90% / ++, 50% / +, 0.5% / +, 1% / ++ / Malignant
H1 / F / 46 / Breast / Invasive ductal carcinoma / 2 / I / T1cN0M0 / +++, 90% / ++, 90% / +++, 100% / - / +++ / Malignant
H2 / F / 34 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N0M0 / - / - / +++, 99% / ++, 5% / ++ / Malignant
H3 / F / 34 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N0M0 / - / - / - / ++, 10% / ++ / Malignant
H4 / F / 45 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N0M0 / - / - / - / - / - / Malignant
H5 / F / 45 / Breast / Invasive ductal carcinoma / 2 / IIb / T3N0M0 / - / - / +++, 99% / +, 1% / - / Malignant
H6 / F / 63 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +++, 99% / +, 1% / + / Malignant
H7 / F / 63 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / ++, 20% / +, 1% / + / Malignant
H8 / F / 35 / Breast / Invasive ductal carcinoma / 3 / IIa / T2N0M0 / - / - / ++, 20% / ++, 90% / - / Malignant
H9 / F / 35 / Breast / Invasive ductal carcinoma / 3 / IIa / T2N0M0 / - / - / - / ++, 50% / + / Malignant
H10 / F / 30 / Breast / Invasive ductal carcinoma / 2 / IIIb / T4N0M0 / +++, 100% / +++, 100% / - / ++, 10% / ++ / Malignant
H11 / F / 30 / Breast / Invasive ductal carcinoma / 2 / IIIb / T4N0M0 / +++, 100% / +++, 100% / - / +++, 20% / ++ / Malignant
H12 / F / 43 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / +++, 100% / - / ++, 10% / - / Malignant
H13 / F / 43 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / +++, 99% / - / ++, 10% / - / Malignant
H14 / F / 54 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / ++, 90% / +++, 98% / - / +++, 85% / +++ / Malignant
H15 / F / 54 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / ++, 80% / +++, 90% / +++, 40% / +++, 85% / +++ / Malignant
I1 / F / 58 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +, 10% / ++, 20% / +++ / Malignant
I2 / F / 58 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +, 5% / ++, 20% / +++ / Malignant
I3 / F / 60 / Breast / Invasive ductal carcinoma / - / IIa / T2N0M0 / - / - / +, 10% / - / - / Malignant
I4 / F / 60 / Breast / Invasive ductal carcinoma / - / IIa / T2N0M0 / - / - / - / - / - / Malignant
I5 / F / 52 / Breast / Invasive ductal carcinoma / 3 / IIa / T2N0M0 / +++, 90% / +++, 90% / - / +, 0.5% / ++ / Malignant
I6 / F / 52 / Breast / Invasive ductal carcinoma / 3 / IIa / T2N0M0 / +++, 80% / +++, 60% / - / +, 0.5% / ++ / Malignant
I7 / F / 48 / Breast / Invasive ductal carcinoma / 3 / I / T1N0M0 / - / - / - / ++, 20% / +++ / Malignant
I8 / F / 48 / Breast / Invasive ductal carcinoma / 3 / I / T1N0M0 / - / - / +, 10% / ++, 30% / +++ / Malignant
I9 / F / 28 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / ++, 5% / - / +, 30% / ++ / Malignant
I10 / F / 28 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / +, 30% / ++, 50% / ++, 50% / ++ / Malignant
I11 / F / 44 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / +++, 70% / ++, 40% / - / Malignant
I12 / F / 44 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / - / ++, 50% / - / Malignant
I13 / F / 61 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / - / ++, 1% / - / Malignant
I14 / F / 61 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / - / ++, 1% / - / Malignant
I15 / F / 34 / Breast / Invasive ductal carcinoma / 2--3 / IIb / T3N0M0 / - / - / - / +++, 90% / +++ / Malignant
J1 / F / 34 / Breast / Invasive ductal carcinoma / 3 / IIb / T3N0M0 / - / - / +++, 60% / +++, 90% / ++ / Malignant
J2 / F / 62 / Breast / Invasive ductal carcinoma / 3 / I / T1N0M0 / - / - / +++, 99% / +++, 90% / - / Malignant
J3 / F / 62 / Breast / Invasive ductal carcinoma / 3 / I / T1N0M0 / - / - / +++, 99% / +++, 80% / + / Malignant
J4 / F / 58 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / ++, 50% / +++, 40% / ++ / Malignant
J5 / F / 58 / Breast / Invasive ductal carcinoma / - / IIa / T2N0M0 / - / - / - / +++, 60% / - / Malignant
J6 / F / 56 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / +, 10% / - / +, 10% / + / Malignant
J7 / F / 56 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / - / ++, 10% / + / Malignant
J8 / F / 57 / Breast / Invasive ductal carcinoma / 3 / IIb / T3N0M0 / - / - / +++, 10% / ++, 30% / - / Malignant
J9 / F / 57 / Breast / Invasive ductal carcinoma / 3 / IIb / T3N0M0 / - / - / +++, 30% / ++, 10% / - / Malignant
J10 / F / 63 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / - / ++, 80% / ++ / Malignant
J11 / F / 63 / Breast / Invasive ductal carcinoma / 2 / IIa / T2N0M0 / - / - / - / ++, 70% / ++ / Malignant
J12 / F / 50 / Breast / Invasive ductal carcinoma / 3 / IIIa / T2N2M0 / - / - / +, 1% / +++, 100% / ++ / Malignant
J13 / F / 50 / Breast / Invasive ductal carcinoma / 3 / IIIa / T2N2M0 / - / - / +, 1% / +++, 100% / ++ / Malignant
J14 / F / 49 / Breast / Invasive ductal carcinoma / 3 / IIa / T2N0M0 / - / - / - / ++, 20% / ++ / Malignant
J15 / F / 49 / Breast / Invasive ductal carcinoma / 3 / IIa / T2N0M0 / - / - / - / +++, 60% / + / Malignant
Table S2. List of TYK2 Matching Peptides
Table S3. List of Strumpellin Matching Peptides